Author

A. Rosner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Organism:rat· 2 Assay:behavioral assay· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:zebrafish· 1

Frequent Co-Authors

B. Politi· 2 shared H. Achdout· 2 shared H. Tamir· 2 shared N. Erez· 2 shared N. Paran· 2 shared S. Melamed· 2 shared S. Weiss· 2 shared S. Yitzhaki· 2 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. Politi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Monitoring group activity of hamsters and mice as a novel tool to evaluate COVID-19 progression, convalescence and rVSV-ΔG-spike vaccination efficacy

S. Melamed, B. Politi, E. Grauer, H. Achdout, M. Aftalion, D. Gur, H. Tamir, Y. Yahalom-Ronen, S. Maimon, E. Yitzhak, S. Weiss, A. Rosner, N. Erez, S. Yitzhaki, S. C. Shapira, , T. Israely

This study uses group activity monitoring in hamsters and mice to assess SARS-CoV-2 infection, convalescence, and vaccine efficacy.

Frontiers in Bioengineering and Biotechnology · Oct 1, 2021Peer-reviewedImmunology

Nonclinical Safety and Immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs

N. Madar-Balakirski, A. Rosner, S. Melamed, B. Politi, M. Steiner, H. Tamir, Y. Yahalom Ronen, E. Bar-David, A. Ben-Shmuel, A. Sittner, I. Glinert, S. Weiss, E. Bar-Haim, H. Cohen, U. Elia, , H. Marcus

This study evaluates the safety, immunogenicity, and efficacy of an rVSV-ΔG-SARS-CoV-2-S vaccine in multiple animal species, finding no adverse effects and a robust immune response.

bioRxiv · Jul 6, 2021Pharmacology & Toxicology